Dr. Iva Navratilova – founder, chief scientific officer

Dr Iva Navratilova has over 17 years experience in biosensor technology development and is the pioneer of the application of SPR screening methods for membrane proteins.


Prof. Andrew L. Hopkins – founder, managing director

Professor Andrew Hopkins is an internationally recognized innovator in drug discovery with over 20 years experience. His concept of 'ligand efficiency' has become an important tool in fragment based drug design.